Recombinant activated factor VII (eptacog alfa activated, NovoSeven ® ) in patients with rare congenital bleeding disorders. A systematic review on its use in surgical procedures

Matteo Nicola Dario Di Minno, Pasquale Ambrosino, Veronika A Myasoedova, Manuela Amato, Itala Ventre, Elena Tremoli, Alessandro Di Minno

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Recombinant activated factor VII (eptacog alfa activated, NovoSeven ® ) in patients with rare congenital bleeding disorders. A systematic review on its use in surgical procedures'. Together they form a unique fingerprint.

Medicine & Life Sciences